NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 201 filers reported holding NEVRO CORP in Q1 2022. The put-call ratio across all filers is 1.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $800,730 | -79.3% | 31,500 | -70.6% | 0.00% | -85.7% |
| Q1 2023 | $3,868,050 | -23.7% | 107,000 | -16.4% | 0.02% | -16.0% |
| Q4 2022 | $5,068,800 | +105.2% | 128,000 | +141.5% | 0.02% | +108.3% |
| Q3 2022 | $2,470,000 | -25.2% | 53,000 | +30.2% | 0.01% | +71.4% |
| Q4 2021 | $3,300,000 | +115.0% | 40,700 | +270.0% | 0.01% | +75.0% |
| Q1 2021 | $1,535,000 | -79.4% | 11,000 | -74.4% | 0.00% | -80.0% |
| Q4 2020 | $7,443,000 | +385.8% | 43,000 | +290.9% | 0.02% | +81.8% |
| Q3 2020 | $1,532,000 | +16.6% | 11,000 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $1,314,000 | -67.7% | 11,000 | -68.2% | 0.01% | -35.3% |
| Q4 2019 | $4,067,000 | – | 34,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
| Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
| Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
| Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
| PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
| Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
| Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
| Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
| HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
| FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |